Using laser treatment to accurately mark astigmatism direction
Application of Phototherapeutic Keratectomy Mode to Mark the Axis of Astigmatism
This study is testing a new laser treatment to see if it can help improve the accuracy of correcting astigmatism during eye surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Tianjin Eye Hospital Academic / other |
| Locations | 1 site (Tianjin, Tianjin Municipality) |
| Trial ID | NCT06694051 on ClinicalTrials.gov |
What this trial studies
This study focuses on improving corneal refractive surgery outcomes by using phototherapeutic keratectomy to accurately mark the axis of astigmatism. The approach involves utilizing excimer laser technology to precisely cut corneal tissue, addressing the common challenge of astigmatism correction in refractive surgery. By accounting for factors such as head position and eye rotation, the study aims to enhance the accuracy of astigmatism treatment. Participants will undergo a procedure that aims to improve the precision of their astigmatism correction.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with astigmatism who do not have any ocular diseases.
Not a fit: Patients with existing ocular diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more effective correction of astigmatism, improving visual outcomes for patients.
How similar studies have performed: While the specific application of this technique may be novel, similar approaches in corneal refractive surgery have shown promise in improving outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * at least 18 years old Exclusion Criteria: * ocular disease
Where this trial is running
Tianjin, Tianjin Municipality
- Tianjin Eye Hospital — Tianjin, Tianjin Municipality, China (Recruiting)
Study contacts
- Study coordinator: Wang
- Email: jiamei3536@163.com
- Phone: +86 022 27313336
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.